Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ProtAffin Biotechnologie AG

www.protaffin.com

Latest From ProtAffin Biotechnologie AG

ProtAffin in the clinic with modified IL-8 for COPD/CF

ProtAffin has begun clinical testing of its lead product candidate, the anti-inflammatory PA401AG, a modified form of the human chemokine IL-8.

Orthopedics Respiratory

Scrip Intelligence presents its latest Roundtable on Managing Biotechs

Scrip Intelligence has released its latest Roundtable discussion, Capital Efficiency: Managing Biotechs in Straitened Times.

Dermatology

Scrip Intelligence presents its latest Roundtable on Managing Biotechs

Scrip Intelligence has released its latest Roundtable discussion, Capital Efficiency: Managing Biotechs in Straitened Times.

Dermatology

ProtAffin awarded €2.7 million to fund preclinical COPD candidate

ProtAffin has received further funding from the Austrian public funding body FFG for its preclinical chronic obstructive pulmonary disease (COPD) candidate PA401.

Orthopedics Respiratory
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Austria
  • Parent & Subsidiaries
  • ProtAffin Biotechnologie AG
  • Senior Management
  • Jason Slingsby, PhD, CEO
    Andreas Kungl, CSO
  • Contact Info
  • ProtAffin Biotechnologie AG
    Phone: (43) 316 382 541
    Impulszentrum Graz-W.,Reininghausstrasse
    13a
    Graz, A-8020
    Austria
Advertisement
Advertisement
UsernamePublicRestriction

Register